17 / September / 2024 New uses for existing drugs International programs weigh up costs and benefits in the search for new forms of treatment with existing drugs Por Editorial staff
02 / September / 2024 Telemedicine guidelines reduce unnecessary prescriptions Study shows that the adoption of specific care guidelines reduced the prescription of antibiotics and antimicrobials for COVID-19 patients Por Editorial staff
28 / August / 2024 Sidarta Ribeiro: “Psychedelics could revolutionize medical practice” Neuroscientist explains why this field of research holds promise in mental health, neurology, and knowledge exchange with Indigenous peoples Por Flavio Lobo
23 / August / 2024 AI increases colonoscopy rates in the US New York study used digital technology to identify cancer patients who missed colonoscopy exams Por Editorial staff
21 / August / 2024 The atlas that could revolutionize medicine An international consortium, supported by Brazilian researchers, reveals details of the human body’s molecular composition and operations at a cellular level Por Gilberto Stam
19 / August / 2024 How climate change impacts the health of Latin Americans A report published in The Lancet by Latin American scientists warns that worsening diseases and economic losses could significantly affect poorer populations Por Letícia Naísa
14 / August / 2024 The urgent need for green medicine Pharmaceutical pollution of ecosystems is a threat to biodiversity, ecosystem services, and public health Por Editorial staff
09 / August / 2024 Bioethics and AI: what role do clinicians and patients play? Researchers identify problems with the use of programs such as ChatGPT in the clinician-patient relationship and suggest how to make better use of AI tools Por Editorial staff
02 / July / 2024 We need to steer technological change The innovations we need cannot depend solely on spontaneous discoveries prompted by curiosity Por André Tortato Rauen
25 / June / 2024 Jorge Kalil: Making vaccines in Brazil is like David versus Goliath The country is not investing enough in the technology needed to develop and produce vaccines for the biggest threats to public health, says the former Butantan director Por Moura Leite Netto
